EXI3:F:F-iShares Dow Jones Industrial Average UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 367.9

Change

0.00 (0.00)%

Market Cap

N/A

Volume

33.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.06 (-0.11%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

+7.42 (+1.34%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 108.41B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.03 (-0.19%)

USD 52.77B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

+1.48 (+1.51%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 46.87B
0ZC:F Zscaler Inc

+6.85 (+2.71%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.68%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+1.10 (+0.87%)

USD 24.77B

ETFs Containing EXI3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.40% 16% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.40% 16% F 34% F
Trailing 12 Months  
Capital Gain 4.87% 51% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.87% 49% F 52% F
Trailing 5 Years  
Capital Gain 60.69% 66% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 60.69% 66% D+ 49% F
Average Annual (5 Year Horizon)  
Capital Gain 11.74% 79% B- 70% C-
Dividend Return 11.74% 76% C+ 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.41% 64% D 91% A-
Risk Adjusted Return 112.75% 97% N/A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike